These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20956357)
21. Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and -sensitive parasites. Walcourt A; Loyevsky M; Lovejoy DB; Gordeuk VR; Richardson DR Int J Biochem Cell Biol; 2004 Mar; 36(3):401-7. PubMed ID: 14687919 [TBL] [Abstract][Full Text] [Related]
22. Trypanotoxic activity of thiosemicarbazone iron chelators. Ellis S; Sexton DW; Steverding D Exp Parasitol; 2015 Mar; 150():7-12. PubMed ID: 25595343 [TBL] [Abstract][Full Text] [Related]
23. Synthesis and characterization of quinoline-based thiosemicarbazones and correlation of cellular iron-binding efficacy to anti-tumor efficacy. Serda M; Kalinowski DS; Mrozek-Wilczkiewicz A; Musiol R; Szurko A; Ratuszna A; Pantarat N; Kovacevic Z; Merlot AM; Richardson DR; Polanski J Bioorg Med Chem Lett; 2012 Sep; 22(17):5527-31. PubMed ID: 22858101 [TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of HIV-1 Tat by CDK2 in HIV-1 transcription. Ammosova T; Berro R; Jerebtsova M; Jackson A; Charles S; Klase Z; Southerland W; Gordeuk VR; Kashanchi F; Nekhai S Retrovirology; 2006 Nov; 3():78. PubMed ID: 17083724 [TBL] [Abstract][Full Text] [Related]
25. Iron chelators of the dipyridylketone thiosemicarbazone class: precomplexation and transmetalation effects on anticancer activity. Bernhardt PV; Sharpe PC; Islam M; Lovejoy DB; Kalinowski DS; Richardson DR J Med Chem; 2009 Jan; 52(2):407-15. PubMed ID: 19090766 [TBL] [Abstract][Full Text] [Related]
26. The Anticancer Agent, Di-2-Pyridylketone 4,4-Dimethyl-3-Thiosemicarbazone (Dp44mT), Up-Regulates the AMPK-Dependent Energy Homeostasis Pathway in Cancer Cells. Krishan S; Richardson DR; Sahni S Biochim Biophys Acta; 2016 Dec; 1863(12):2916-2933. PubMed ID: 27639899 [TBL] [Abstract][Full Text] [Related]
27. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation. Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242 [TBL] [Abstract][Full Text] [Related]
28. Dephosphorylation of CDK9 by protein phosphatase 2A and protein phosphatase-1 in Tat-activated HIV-1 transcription. Ammosova T; Washington K; Debebe Z; Brady J; Nekhai S Retrovirology; 2005 Jul; 2():47. PubMed ID: 16048649 [TBL] [Abstract][Full Text] [Related]
29. Flavonoid-based inhibition of cyclin-dependent kinase 9 without concomitant inhibition of histone deacetylases durably reinforces HIV latency. Schonhofer C; Yi J; Sciorillo A; Andrae-Marobela K; Cochrane A; Harris M; Brumme ZL; Brockman MA; Mounzer K; Hart C; Gyampoh K; Yuan Z; Montaner LJ; Tietjen I Biochem Pharmacol; 2021 Apr; 186():114462. PubMed ID: 33577894 [TBL] [Abstract][Full Text] [Related]
30. Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity. Richardson DR; Sharpe PC; Lovejoy DB; Senaratne D; Kalinowski DS; Islam M; Bernhardt PV J Med Chem; 2006 Nov; 49(22):6510-21. PubMed ID: 17064069 [TBL] [Abstract][Full Text] [Related]
31. Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron pool. Walcourt A; Kurantsin-Mills J; Kwagyan J; Adenuga BB; Kalinowski DS; Lovejoy DB; Lane DJ; Richardson DR J Inorg Biochem; 2013 Dec; 129():43-51. PubMed ID: 24028863 [TBL] [Abstract][Full Text] [Related]
32. Determining the Functions of HIV-1 Tat and a Second Magnesium Ion in the CDK9/Cyclin T1 Complex: A Molecular Dynamics Simulation Study. Jin HX; Go ML; Yin P; Qiu XT; Zhu P; Yan XJ PLoS One; 2015; 10(4):e0124673. PubMed ID: 25909811 [TBL] [Abstract][Full Text] [Related]
34. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes. Salerno D; Hasham MG; Marshall R; Garriga J; Tsygankov AY; Graña X Gene; 2007 Dec; 405(1-2):65-78. PubMed ID: 17949927 [TBL] [Abstract][Full Text] [Related]
35. Future of toxicology--iron chelators and differing modes of action and toxicity: the changing face of iron chelation therapy. Kalinowski DS; Richardson DR Chem Res Toxicol; 2007 May; 20(5):715-20. PubMed ID: 17402750 [TBL] [Abstract][Full Text] [Related]
36. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. Sawaya BE; Khalili K; Gordon J; Taube R; Amini S J Biol Chem; 2000 Nov; 275(45):35209-14. PubMed ID: 10931842 [TBL] [Abstract][Full Text] [Related]
37. AZ703, an imidazo[1,2-a]pyridine inhibitor of cyclin-dependent kinases 1 and 2, induces E2F-1-dependent apoptosis enhanced by depletion of cyclin-dependent kinase 9. Cai D; Byth KF; Shapiro GI Cancer Res; 2006 Jan; 66(1):435-44. PubMed ID: 16397259 [TBL] [Abstract][Full Text] [Related]
38. Intracellular reduction/activation of a disulfide switch in thiosemicarbazone iron chelators. Akam EA; Chang TM; Astashkin AV; Tomat E Metallomics; 2014 Oct; 6(10):1905-12. PubMed ID: 25100578 [TBL] [Abstract][Full Text] [Related]
39. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription. Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463 [TBL] [Abstract][Full Text] [Related]